CA67108/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1995	1
1996	2
1997	3
1998	7
1999	5
2000	7
2001	2
2002	3
2003	14
2004	4
2005	11
2006	4
2007	6
2008	2
2021	0

1

Mechanisms of tumor evasion.

Campoli M, Ferrone S, Zea AH, Rodriguez PC, Ochoa AC. Campoli M, et al. Cancer Treat Res. 2005;123:61-88. doi: 10.1007/0-387-27545-2_3. Cancer Treat Res. 2005. PMID: 16211866 Review.

2

Antigen-processing machinery breakdown and tumor growth.

Seliger B, Maeurer MJ, Ferrone S. Seliger B, et al. Immunol Today. 2000 Sep;21(9):455-64. doi: 10.1016/s0167-5699(00)01692-3. Immunol Today. 2000. PMID: 10953098 Review.

3

HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications.

Campoli M, Chang CC, Oldford SA, Edgecombe AD, Drover S, Ferrone S. Campoli M, et al. Breast Dis. 2004;20:105-25. doi: 10.3233/bd-2004-20112. Breast Dis. 2004. PMID: 15687712 Review. No abstract available.

4

HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

Seliger B, Abken H, Ferrone S. Seliger B, et al. Trends Immunol. 2003 Feb;24(2):82-7. doi: 10.1016/s1471-4906(02)00039-x. Trends Immunol. 2003. PMID: 12547505 Review.

5

HLA class I antigen abnormalities and immune escape by malignant cells.

Seliger B, Cabrera T, Garrido F, Ferrone S. Seliger B, et al. Semin Cancer Biol. 2002 Feb;12(1):3-13. doi: 10.1006/scbi.2001.0404. Semin Cancer Biol. 2002. PMID: 11926409 Review. No abstract available.

6

Immune selective pressure and HLA class I antigen defects in malignant lesions.

Chang CC, Ferrone S. Chang CC, et al. Cancer Immunol Immunother. 2007 Feb;56(2):227-36. doi: 10.1007/s00262-006-0183-1. Epub 2006 Jun 17. Cancer Immunol Immunother. 2007. PMID: 16783578 Review.

7

HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?

Chang CC, Campoli M, Ferrone S. Chang CC, et al. Curr Opin Immunol. 2004 Oct;16(5):644-50. doi: 10.1016/j.coi.2004.07.015. Curr Opin Immunol. 2004. PMID: 15342012 Review.

8

NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.

Chang CC, Ferrone S. Chang CC, et al. Semin Cancer Biol. 2006 Oct;16(5):383-92. doi: 10.1016/j.semcancer.2006.07.001. Epub 2006 Jul 7. Semin Cancer Biol. 2006. PMID: 16931041 Review.

9

Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.

Chang CC, Murphy SP, Ferrone S. Chang CC, et al. Hum Immunol. 2003 Nov;64(11):1057-63. doi: 10.1016/j.humimm.2003.08.357. Hum Immunol. 2003. PMID: 14602236 Review.

10

HLA class I antigen loss, tumor immune escape and immune selection.

Campoli M, Chang CC, Ferrone S. Campoli M, et al. Vaccine. 2002 Dec 19;20 Suppl 4:A40-5. doi: 10.1016/s0264-410x(02)00386-9. Vaccine. 2002. PMID: 12477427 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results